SMTL ID : 9qe5.3 (3 other biounits)

VCB in complex with VHL-binding compound 82

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x 01: (2~{S},4~{R})-1-[(2~{S})-1-(1-fluoranylcyclopropyl)carbonylpiperidin-2-yl]carbonyl-~{N}-[(1~{S})-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide

01.1: 16 residues within 4Å: Chain C: N.57, R.59, F.66, P.76, W.78, F.81, Y.88, P.89, L.91, R.97, I.99, H.100, S.101, Y.102, H.105, W.107 13 PLIP interactions: 13 interactions with chain C Hydrophobic interactions: C:R.59, C:W.78, C:F.81, C:I.99, C:I.99, C:H.100, C:W.107 Hydrogen bonds: C:R.97, C:H.100, C:S.101, C:Y.102, C:H.105 pi-Stacking: C:Y.88

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wittenburg, S. et al., Breaking Barriers in PROTAC Design: Improving Solubility of USP7-Targeting Degraders. To Be Published

Release Date

2025-04-23

Peptides

Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
G

B
H

C
I

Elongin-B

Elongin-C

von Hippel-Lindau disease tumor suppressor

Related Entries With Identical Sequence